OHSU heart transplant review set to begin
About three months after Oregon Health& Science University suspended its Heart Transplant Program indefinitely, an outside peer review is scheduled to begin on Monday.
The peer review and assessment of the transplant program and Knight Cardiovascular Institute are “privileged, confidential and exempt from public disclosure,” although OHSU will share updates with the public, said spokeswoman Tamara Hargens-Bradley.
The health care profession often uses indep endent peer review to allow team…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news
More News: Cardiology | Cardiovascular | Health Management | Heart | Heart Transplant | Science | Transplant Surgery | Transplants